MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
BIOLASE DPO Ratio 2011-2026 | BIOL
Annual DPO Ratio BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.7 | 51 | 48 | 87.7 | 82.8 | 74.3 | 58.6 | 106 | 66.9 | 103 | 89.5 | 90.6 | 103 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 106 | 48 | 79.1 |
Quarterly DPO Ratio BIOLASE
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.9 | 68.3 | 73.7 | - | 85.8 | 77.4 | 85.3 | - | 47.4 | 61.8 | 66.7 | - | 69.1 | 58.9 | 48.6 | - | 56.7 | 121 | 106 | - | 85.7 | 92.4 | 75.7 | - | 77.7 | 69.2 | 72.2 | - | 58.6 | 59 | 93.8 | - | 109 | 102 | 93.4 | - | 69.2 | 66.6 | 85.4 | - | 104 | 118 | 102 | - | 91.7 | 89.9 | - | - | 93.2 | 89.5 | 108 | - | 92 | 110 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 121 | 47.4 | 82.4 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
33.7 | $ 184.69 | 2.23 % | $ 13.8 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
34.4 | $ 34.46 | 2.96 % | $ 1.59 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.77 | 3.65 % | $ 1.73 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 292.23 | 1.41 % | $ 8.24 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.37 | 1.35 % | $ 126 M |  France |
 |
Bruker Corporation
BRKR
|
46.4 | $ 39.9 | 2.18 % | $ 5.94 K | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 63.82 | 1.01 % | $ 94.5 B | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.59 | 0.67 % | $ 36.7 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 10.38 | 3.7 % | $ 294 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 25.21 | 1.47 % | $ 213 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.98 | -2.46 % | $ 1.2 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.34 | -1.71 % | $ 169 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.03 | - | $ 17.4 M | USA |
 |
Globus Medical
GMED
|
33.1 | $ 94.94 | 2.11 % | $ 12.8 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.86 | 5.37 % | $ 419 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.44 | 3.74 % | $ 940 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
LENSAR
LNSR
|
146 | $ 6.04 | 2.03 % | $ 72.2 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 10.88 | 4.11 % | $ 390 M | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 56.83 | 3.48 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 39.73 | 3.3 % | $ 1.23 B | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 64.99 | 0.63 % | $ 3.55 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 88.63 | 1.03 % | $ 3.08 B | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.76 | 0.27 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 78.2 | 0.1 % | $ 45.7 B | USA |
 |
Myomo
MYO
|
34.8 | $ 0.79 | 8.49 % | $ 33.1 M | USA |